MARK4 and non-small cell lung carcinoma: We showed that MARK4 silencing reproduces the morphological and cell migration changes observed following miR‐515‐5p overexpression in both breast and NSCLC cells, demonstrating this to be a consistent phenomenon across two separate tumour types.